Recombinant human acid alpha-glucosidase (rhGAA)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
256	筋型糖原病	6

256. 筋型糖原病

臨床試験数 : 180 / 薬物数 : 133 - (DrugBank : 29) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 105

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-002759-42-DE (EUCTR)	18/07/2007	24/07/2009	A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Effi ...	A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Effi ...	Glycogen Storage Disease type II (Pompe's disease) MedDRA version: 9.1;Level: LLT;Classification cod ...	Trade Name: Myozyme Product Name: Myozyme INN or Proposed INN: Alglucosidase alfa Other descriptive nam ...	Genzyme Europe BV	NULL	Not Recruiting			Female: yes Male: yes	90		Germany
2	EUCTR2005-002829-31-GB (EUCTR)	31/08/2005	07/07/2005	Full title of the trial : A Single Centre, Open-Label, Bridging Study of the Safety, Pharmacokinetic ...	Full title of the trial : A Single Centre, Open-Label, Bridging Study of the Safety, Pharmacokinetic ...	Glycogen Storage Disease type II (Pompe´s disease)	Product Name: Myozyme Product Code: rhGAA, acidalpha glucosidase INN or Proposed INN: Alglucosidase al ...	Genzyme Europe BV	NULL	Not Recruiting			Female: yes Male: yes	5	Phase 2	Belgium;United Kingdom
3	EUCTR2004-002168-59-IT (EUCTR)	14/10/2004	03/01/2005	An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharm ...	An Open-Label, Multicenter, Multinational, Study of the Safety, Efficacy,Pharmacokinetics, and Pharm ...	Treatment for Type II Glycogenosis MedDRA version: 6.1;Level: PT;Classification code 10053185	Product Name: Recombinant human acidalfa-glucosidase (rhGAA) Product Code: NA INN or Proposed INN: alg ...	GENZYME	NULL	Not Recruiting			Female: yes Male: yes	20		Italy
4	NCT00051935 (ClinicalTrials.gov)	January 2003	17/1/2003	A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type I ...	Open-Label, Pilot Study of the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Human Ac ...	Glycogen Storage Disease Type II;Pompe Disease;Acid Maltase Deficiency Disease;Glycogenosis 2	Drug: Alglucosidase alfa	Genzyme, a Sanofi Company	NULL	Completed	N/A	N/A	Both	2	Phase 2	United States
5	NCT00025896 (ClinicalTrials.gov)	May 2001	31/10/2001	Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidasein the Treatment of Classical Infanti ...	A Prospective Multinational, Multicenter, Clinical Trial of the Safety and Efficacy of Recombinant H ...	Pompe Disease;Glycogen Storage Disease Type II;Acid Maltase Deficiency Disease;Glycogenosis 2	Drug: recombinant human acid alpha-glucosidase (rhGAA)	Genzyme, a Sanofi Company	NULL	Completed	N/A	N/A	Both	8	Phase 2	United States
6	EUCTR2005-002829-31-BE (EUCTR)		09/02/2006	Full title of the trial : A Single Centre, Open-Label, Bridging Study of the Safety, Pharmacokinetic ...	Full title of the trial : A Single Centre, Open-Label, Bridging Study of the Safety, Pharmacokinetic ...	Glycogen Storage Disease type II (Pompe´s disease)	Product Name: Myozyme Product Code: rhGAA, acidalpha glucosidase INN or Proposed INN: Alglucosidase al ...	Genzyme Europe BV	NULL	Not Recruiting			Female: yes Male: yes	5	Phase 2	Belgium;United Kingdom

First Previous1Next Last